referring to indianexpress
Sun Pharma, ICGEB tie up to develop dengue vaccine
Sun Pharma, ICGEB tie up to develop dengue vaccine
After announcing an agreement to develop a drug for dengue in May this year, Sun Pharmaceuticals and International Centre for Genetic Engineering and Biotechnology (ICGEB) on Wednesday signed another agreement — this time to develop a vaccine for dengue.The vaccine is expected to target all the four serotypes of dengue virus.Over the past seven years, ICGEB has conducted the pre-clinical studies and developed the know-how and patents for this dengue vaccine candidate.
besides business-standard
Sun enters vaccine space with dengue shot
Sun enters vaccine space with dengue shot
has entered the business with an antidote for all four serotypes of dengue.The company will develop this vaccine on transfer by the transferred of its patent.will tie up with manufacturing units to produce the vaccine because it does not have separate facilities for this purpose.
coupled with hindustantimes
First made-in-India dengue vaccine candidate protects against all 4 strains
First made-in-India dengue vaccine candidate protects against all 4 strains
India has developed an indigenous dengue vaccine candidate that offers protection from all four strains in clinical stages, a drug major announced on Wednesday, raising hopes of an effective shield against a disease that afflicts thousands of people in the country annually.However, it is yet to be tested on humans and could take up to eight to 10 years to be available to the public."I'm really happy today as a lot of good research in India is known to never see the light of day.
No comments:
Post a Comment